Drawing for HEMOCUE

USPTO serial 79416209

HEMOCUE

Reviewed by CopyMark Law Group

Reg. 7954213Status 700Registered
Filing date
Status date
Registration date
Sep 23, 2025
Examiner
MANCA, ALBERTO I
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HEMOCUE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Shima Roy

Shima Roy Baker Mckenzie LLP300 E Randolph StSuite 5000Chicago, IL 60601

Goods and services

ClassDescriptionStatusFirst use
009Computers; electric and electronic apparatus for laboratory analysis, namely, point-of-care electronic testing devices for the measurement of biological materials and taking of biological measurements in the nature of hand-held and portable photometers and liquid analyzers for clinical and laboratory use; scientific apparatus and instruments, namely, spectrophotometers and photometers for providing cell and particle analysis, detection, and counting for clinical, laboratory, and general research uses; measuring apparatus and instruments, namely, monitors, photometers, and analyzers for the measurement of the levels of different substances and compounds in bodily fluids; electronic measuring devices, namely, photometers and liquid analyzers for biological measurements; laboratory analyzers, namely, clinical laboratory liquid analyzers for the measurement determination of biological materials and taking of biological measurements; research laboratory analyzers for measuring, testing and analysing blood and other bodily fluids; point-of-care electronic testing devices for the measurement of biological materials in the nature of bodily fluids and taking of biological measurements from bodily fluids; electronic testing devices for the measurement of biological materials in the nature of bodily fluids and taking of biological measurements from bodily fluids; point-of-care electronic testing devices for the measurement of biological materials and taking of biological measurements, namely, hand-held and portable photometers and liquid analyzers for clinical and laboratory use; laboratory electronic apparatus, namely, clinical laboratory liquid analyzers for biological measurement determination; laboratory electronic apparatus for the measurement determination of biological materials and taking of biological measurements, namely, clinical laboratory liquid analyzers; electronic equipment used for performing biologic measurements for clinical laboratory and laboratory use, namely, photometers and liquid analyzers; scientific and measuring apparatus and instruments for clinical laboratory and laboratory use, namely, monitors, photometers, and liquid analyzers for the measurement of the levels of different substances and compounds in bodily fluids; photometers and spectrophotometers; spectrophotometers and photometers for providing cell and particle analysis, detection, and counting for clinical laboratory, laboratory, and general research uses; electronic sensors for measuring liquids, namely, monitors, photometers, and analyzers for measuring bodily fluids; testing and quality control devices namely, apparatus for testing liquids and electrical outlet testers; quality control materials for calibration purposes, namely, calibrators being calibrating devices for use in calibrating and verifying the accuracy of photometers and electronic sensors used for measuring liquids; cuvettes and microcuvettes made from polymer materials for clinical laboratory and laboratory use; holders specially adapted for polymer cuvettes and microcuvettes; laboratory analytical apparatus, namely, polymer cuvettes suitable for the measurements of the levels of different substances and compounds in bodily fluids; downloadable data and file management software; downloadable database management software for managing patient medical records; computer software for use in medical measuring, screening, monitoring, diagnostics and analysis, namely, downloadable computer software for monitoring patient vital signs; downloadable health monitoring software for monitoring blood sugar levels; downloadable computer software for the measurement of biological materials and taking of biological measurements; downloadable computer software for the measurement of biological materials and taking of biological measurements, namely, downloadable biological measurement data management and biological measurement data analysis software; computer docking stations; electronic docking stations; photometers for providing cell and particle analysis, detection, and counting for medical and clinical laboratory uses; research laboratory bodily fluid analyzers for providing cell and particle analysis, detection, and counting for clinical laboratory uses; diagnostic apparatus and instruments for research and laboratory use, not for medical purposes, in particular for the measurement of biological materials and taking of biological measurements, namely, photometers; scientific instruments for diagnosis for research use, namely, laboratory centrifuges, microscopes, and probes for scientific purposesACTIVE—
010Medical apparatus and instruments, namely, apparatus for medical analysis for the measurement of biological materials and taking of biological measurements, namely, bodily fluid monitors and analyzers for medical use; electronic analyzers for medical purposes, namely, for measuring blood glucose for medical purposes; bodily fluid analyzers for providing cell and particle analysis, detection, and counting for medical diagnostic, and therapeutic uses; automatic analyzers for medical diagnosis in the nature of hematology analyzers, sample preparation device, and embedded data management software sold as a unit; medical diagnostic instruments, namely, automated analyzers for body fluids for medical purposes; diagnostic measuring apparatus for medical use, namely, devices for measuring blood glucose and hemoglobin for medical purposes; bodily fluid analyzers for providing cell and particle analysis, detection, or counting for medical, medical diagnostic, and therapeutic uses; medical apparatus and instruments for medical analysis for the measurement of biological materials and taking of biological measurements; medical diagnostic instruments in the nature of bodily fluid monitors and analyzers; diabetic monitoring apparatus, namely, glucose meters, medical test kits for diabetic monitoring for home use; devices for blood monitoring blood properties for medical use; blood glucose monitoring apparatus, namely, devices for monitoring blood glucose for medical purposes; apparatus for blood tests for medical use; apparatus for blood analysis; hemocytometers being apparatus for blood analysis; devices for measuring blood glucose for medical purposes, namely, devices for monitoring blood glucose levels; blood glucose testing apparatus, namely, devices for monitoring blood glucose for medical purposes; blood glucose meters; apparatus for blood analysis, namely, blood analyzers; bodily fluid analyzers being medical diagnostic instruments for the analysis of bodily fluids, namely, bodily fluid analyzers for providing cell and particle analysis, detection, and counting for medical, medical diagnostic, and therapeutic uses; instrument and apparatus systems for medical diagnostic uses consisting of hematology analyzers, sample preparation device, and embedded data management software sold as a unit; automated blood collection apparatus and instruments; apparatus for carrying out diagnostic tests for medical purposes, namely, medical diagnosis apparatus for testing blood sugar levels and medical diagnostic apparatus for testing hemoglobin levels; medical test kits for diabetes monitoring for home useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 23, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jul 17, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 17, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 17, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 17, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 17, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 6, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 5, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 23, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 3, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 2, 2026FIMPFINAL DISPOSITION PROCESSED—
Dec 23, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 23, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Sep 23, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 23, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Sep 23, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 23, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 23, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 23, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 5, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 5, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 30, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 1, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 27, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Jun 27, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 27, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 27, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 12, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 12, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 12, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 26, 2025RFNTREFUSAL PROCESSED BY IB—
Apr 8, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 8, 2025RFRRREFUSAL PROCESSED BY MPU—
Mar 28, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 4, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 3, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 28, 2025DOCKASSIGNED TO EXAMINER—
Feb 7, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 7, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 6, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance